Pfizer Limited
PFIZER (NSE)

4,086.45

0.00
Proj. ROE (%)
20.10
Proj. P/E (x)
29.08
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
5.85
Proj. Revenue ( Cr.)
2,750.58

Stock View

BUY
Share on
The average score for Pfizer Limited stands at 3 against 6, three months back.

Pfizer Limited is an India-based pharmaceutical company. The Company has a portfolio of approximately 150 products across over 15 therapeutic areas. The Company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The Company offers a range of products for anti-diabetic, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins, neurology, pain/fever/inflammation and autoimmune disorders, among others. Its products include Trulimax, Vibazime DT, Viagra, Daxid, Tricorex, Mucaine, Diamox, Hetrazan, Enbrel, Ativan, Pacitane, Folvite Tablets, Autrin Capsules, Prevenar 13, Wysolone, Loette, Ovral G, Ovral L, Premarin tablets, Premarin Vaginal Cream, Zosyn, Wymox, Tygacil, Cynomycin, Targit, Cyklokapron and Magnamycin. The Company has its own manufacturing facility at Thane and Goa. The Company has various independent contract/third party manufacturers based across the country.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
4,243.54
100 DMA ()
4,325.66
200 DMA ()
4,751.46
52 Weeks Range
4,070.00
6,175.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity